Abstract:Background: Radiotherapy (RT) is a primary treatment for cancers of the head and neck. However, although highly efficacious in eliminating tumors, incidental damage to underlying tissue remains a major limitation of RT. In the case of head and neck cancer, damage to the otherwise healthy salivary glands is often unavoidable even at low dosages, leaving patients with lifelong xerostomia and other comorbidities. FLASH Proton RT (F-PRT) is a form of ultra-high dose RT and has been reported to spare healthy tissues while retaining its tumor-controlling efficacy. The first system to deliver dosimetrically identical FLASH Proton RT (F-PRT; 60- 110 Gy/sec) or Standard Proton RT (S-PRT; 0.5-1 Gy/sec) using double-scattered protons was designed by our group. Aim: In this study, we aimed to investigate the effect of F-PRT on radiation-induced salivary gland dysfunction and the potential mechanism of this sparing effect by analyzing the effects of FLASH on two distinct salivary gland cell types: acinar and ductal cells. Methods: The head and neck area of C57BL/6 mice were irradiated with a single dose of 16 Gy of F-PRT (128Gy/s) or S-PRT (0.95 Gy/s). Radiation-induced xerostomia was studied by measuring the saliva flow rate of mice at 5, 10, 14, and 28 days post-PRT. Expression of AQP5, SOX9, and Keratin- 18, 19 was studied at 2, 5, 10, 14, and 28 days post irradiation by both immunofluorescence and protein immunoblotting. Results: Following irradiation with a single dose of 16 Gy, saliva flow was reduced by both treatments. However, the F-PRT-treated mice showed a significant improvement in salivary flow at 14 and 28 days post-irradiation, compared to those treated with S-PRT. Expression of AQP5 was significantly downregulated at 2, 5, 10 and 14 days post irradiation with S-PRT while F-PRT-treated mice showed a significant restoration of the AQP5 expression during the same time points. Expression of SOX9 showed no significant differences between S-PRT and F-PRT treated mice at earlier time points (2, 14 days), however, there was a significant difference in expression of SOX9 between the irradiated and unirradiated group. The difference in expression of SOX9 was visible from day 28 post-irradiation, where the F-PRT treated group showed increased expression compared to S-PRT. Conclusion: Our findings demonstrate that F-PRT reduces radiation-induced hyposalivation and reinstates the expression of AQP5 in the acinar cells of the submandibular gland of mice. Furthermore, it demonstrates that on day 28 post-irradiation, F-PRT-treated mice displayed more SOX9-expressing progenitor cells in the submandibular salivary glands compared to S-PRT. Acknowledgements: This work was supported by a Sponsored Research Agreement from IBA to Drs. C. Koumenis and L. Dong. Citation Format: George S. Morcos, Priyanka Chowdhury, Michele M. Kim, Khayrullo Shoniyozov, James Metz, Lei Dong, Constantinos Koumenis. Investigating the mechanisms behind salivary gland tissue sparing in response to ultra-high dose-rate FLASH proton radiotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6022.

Artesunate alleviates radiation‐induced submandibular gland epithelial cell damage in rats by reducing inflammation and apoptosis

Salidroside Ameliorates Radiation Damage by Reducing Mitochondrial Oxidative Stress in the Submandibular Gland

Tetrahedral framework nucleic acids alleviate irradiation-induced salivary gland damage

Rapamycin alleviates irradiation‐induced parotid injury by enhancing the whole gland homeostasis

Glycyrrhizin Protects Submandibular Gland Against Radiation Damage by Enhancing Antioxidant Defense and Preserving Mitochondrial Homeostasis

Decreased saliva secretion and down-regulation of AQP5 in submandibular gland in irradiated rats.

Abstract 7446: Transcriptomic and histological analysis of radiation-induced damage in the murine submandibular gland

Dietary nitrate supplementation prevents radiotherapy-induced xerostomia

Artesunate Combined With Metformin Ameliorate on Diabetes-Induced Xerostomia by Mitigating Superior Salivatory Nucleus and Salivary Glands Injury in Type 2 Diabetic Rats via the PI3K/AKT Pathway

Abstract 6022: Investigating the mechanisms behind salivary gland tissue sparing in response to ultra-high dose-rate FLASH proton radiotherapy

Function of Dihydroartemisinin on Tumor Necrosis Factor Α in Rats with Earlier Radiation Pulmonary Injury

The Rapalogue, CCI-779, improves salivary gland function following radiation

Mechanism, Prevention, and Treatment of Radiation-Induced Salivary Gland Injury Related to Oxidative Stress

Intragland Expression of the Shh Gene Alleviates Irradiation-Induced Salivary Gland Injury through Microvessel Protection and the Regulation of Oxidative Stress

Artesunate exerts protective effects against ulcerative colitis via suppressing Toll‑like receptor 4 and its downstream nuclear factor‑κB signaling pathways

Artesunate promotes cervical cancer cell apoptosis by regulating Bcl2 family molecules and reducing the mitochondrial membrane potential

Radioprotective Effects and Mechanism of Dicliptera Chinensis Polysaccharide on Submandibular Gland Injury Induced by Radiation in Rats

PANoptosis induced by inflammatory cytokines promotes salivary glands radiation injury

Amifostine and Melatonin Prevent Acute Salivary Gland Dysfunction 10 Days After Radiation Through Anti-Ferroptosis and Anti-Ferritinophagy Effects

Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review

Artesunate attenuates proliferation of epithelial cells by downregulating the NF-κB and AKT signaling pathways in benign mammary gland hyperplasia rats